Treatment with the drug Bracanat ( Lynparza ) is possible for metastatic ovarian or fallopian tube cancer, pancreatic adenocarcinoma, prostate and breast cancer. Olaparib 150mg at the heart of the drug affects tumor cells, preventing them from growing and capturing healthy cells of the body. Bracanat is a measure of therapy when surgical intervention is not necessary or impossible. The medical drug Bracanat is manufactured in India by Natco.